Cargando…
Advanced human mucosal tissue models are needed to improve preclinical testing of vaccines
Many vaccine candidates with promising results in preclinical testing fail in human trials. New complex human tissue models have the potential to improve the predictability of vaccine safety and efficacy in human clinical trials.
Autores principales: | Kessie, David Komla, Rudel, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612770/ https://www.ncbi.nlm.nih.gov/pubmed/34767552 http://dx.doi.org/10.1371/journal.pbio.3001462 |
Ejemplares similares
-
Exploring a need for improved preclinical models of post-stroke depression
por: Mittal, Nitish, et al.
Publicado: (2016) -
Critical Needs in Advancing Shigella Vaccines for Global Health
por: MacLennan, Calman A, et al.
Publicado: (2021) -
Susceptibility of Human Airway Tissue Models Derived From Different Anatomical Sites to Bordetella pertussis and Its Virulence Factor Adenylate Cyclase Toxin
por: Sivarajan, Rinu, et al.
Publicado: (2021) -
Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma
por: Simpson, R Mark, et al.
Publicado: (2014) -
Improving Translational Relevance in Preclinical Psychopharmacology (iTRIPP)
por: Bailey, Sarah J, et al.
Publicado: (2023)